Steven Attia

Also affiliated with Jacksonville College, University Hospital Heidelberg, WinnMed, Dana-Farber Cancer Institute, Mayo Clinic in Arizona, Mayo Clinic in Florida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma”.

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Nature Communications(2022)10.1038/s41467-022-30496-0

N/A

5.2DataRank · unranked

198 citations

Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis +38 more

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

The Lancet(2024)10.1016/s0140-6736(24)01812-9

N/A

1.4DataRank · unranked

84 citations

Karla V. Ballman, Angela Hong, Scott M. Schuetze, Andrew J. Wagner, Varun Monga +23 more

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1824

N/A

0.807DataRank · unranked

216 citations

Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack +18 more

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3817

N/A

0.477DataRank · unranked

23 citations

Rachel S. Heise, Kristen Ganjoo, Elizabeth J. Davis, Suzanne George, Melissa Burgess +16 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11506

N/A

0DataRank · unranked

11 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +15 more

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11503

N/A

0DataRank · unranked

10 citations

Karla V. Ballman, Kristen Ganjoo, Elizabeth J. Davis, Jeffrey A. Morgan, Gabriel Tinoco +15 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps11570

N/A

0DataRank · unranked

6 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +8 more

A randomized phase II study of MLN0128 (M) versus pazopanib (P) in patients (pt) with advanced sarcoma (Alliance A091304).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11562

N/A

0DataRank · unranked

7 citations

Michelle R. Mahoney, Fabrizio Remotti, Ardaman Shergill, Mark A. Dickson, Richard F. Riedel +10 more

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas

Cancers(2020)10.3390/cancers12071873

N/A

0DataRank · unranked

57 citations

Keith M. Skubitz, Seth Maliske, Sarah L. Mott, Hilary Dietz, Angela C. Hirbe +11 more